J E Pandolfino Selected Research

sodium bicarbonate drug combination magnesium trisilicate aluminium hydroxide alginate (Gaviscon)

9/2014	Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study.
7/2011	An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J E Pandolfino Research Topics

Disease

14	Gastroesophageal Reflux (GERD) 01/2018 - 08/2000
3	Esophageal Achalasia (Megaesophagus) 09/2018 - 06/2013
2	Deglutition Disorders (Dysphagia) 01/2018 - 01/2016
2	Pathologic Constriction (Stenosis) 10/2017 - 08/2011
2	Heartburn (Pyrosis) 07/2016 - 07/2011
1	Neoplasms (Cancer) 09/2018
1	Chagas Disease (American Trypanosomiasis) 09/2018
1	Systemic Scleroderma (Systemic Sclerosis) 01/2018
1	Peptic Esophagitis (Reflux Esophagitis) 10/2017
1	Hypersensitivity (Allergy) 10/2017
1	Eosinophilic Esophagitis 12/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2016
1	Esophagitis 09/2015
1	Bile Reflux 11/2013
1	Motor Disorders 03/2012
1	Globus Sensation 09/2010
1	Chest Pain (Chest Pains) 01/2007
1	Foreign Bodies (Foreign Body) 01/2007
1	Hiatal Hernia 01/2006

Drug/Important Bio-Agent (IBA)

8	AcidsIBA 01/2018 - 01/2006
7	Proton Pump InhibitorsIBA 01/2018 - 05/2008
3	beta-Aminoethyl Isothiourea (AET)IBA 01/2018 - 10/2017
2	BariumIBA 01/2018 - 06/2013
2	AlginatesIBA 09/2014 - 07/2011
2	AntacidsIBA 09/2014 - 07/2011
2	sodium bicarbonate drug combination magnesium trisilicate aluminium hydroxide alginate (Gaviscon)FDA Link 09/2014 - 07/2011
2	tetrachloroisophthalonitrile (Bravo)IBA 01/2006 - 12/2005
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2018
1	2-aminoethanethiosulfonic acidIBA 01/2018
1	AutoantibodiesIBA 01/2016
1	Complement System Proteins (Complement)IBA 03/2012
1	MCOIBA 05/2008
1	Capsules (Microcapsules)IBA 01/2007
1	Nicotine FDA Link 08/2000

Therapy/Procedure

10	Therapeutics 01/2018 - 12/2003
2	Catheters 01/2018 - 12/2016
1	Myotomy 09/2018
1	Aftercare (After-Treatment) 01/2018
1	Hypnosis (Mesmerism) 07/2016
1	Stents 08/2011
1	Relaxation Therapy (Relaxation Technique) 09/2010